Cloud computing in pharmaceutical R&D: business risks and mitigations.
Cloud computing provides information processing power and business services, delivering these services over the Internet from centrally hosted locations. Major technology corporations aim to supply these services to every sector of the economy. Deploying business processes 'in the cloud' requires special attention to the regulatory and business risks assumed when running on both hardware and software that are outside the direct control of a company. The identification of risks at the correct service level allows a good mitigation strategy to be selected. The pharmaceutical industry can take advantage of existing risk management strategies that have already been tested in the finance and electronic commerce sectors. In this review, the business risks associated with the use of cloud computing are discussed, and mitigations achieved through knowledge from securing services for electronic commerce and from good IT practice are highlighted.
Geiger
Karl
K
CURE Pharmaceutical, 5706 Corsa, Suite B200 M, Westlake Village, CA 91362, USA. karl_geiger@curepharmaceutical.com
D002986:Clinical Trials as Topic / Q000379:methods*; D003205:Computing Methodologies; D004345:Drug Industry / Q000379:methods*; D008331:Management Information Systems / Q000639:trends*; D012308:Risk Management / Q000379:methods*